The disproportionate burdens of the mifepristone REMS
As long as the FDA’s Risk Evaluation and Mitigation Strategy (REMS) for mifepristone remain in place, it creates an unnecessary barrier to access safe medication for abortion and miscarriage care. This article discusses why it’s critical to permanently remove the REMS to reduce the disproportionate harms of abortion restrictions on communities of color, and advance equity in and access to timely and essential reproductive health care.
CPHLR at APHA 2022
Legal Epidemiology and the Path to Better Health Law and Policy
WEBINAR:
January 21, 2020, 8:00-9:30 a.m. ET
Eviction and the Necessary Conditions for Health
The COVID-19 pandemic both highlighted eviction as a public health crisis and exacerbated the problem. In a new article published today in the New England Journal of Medicine, housing law experts at the Temple University Center for Public Health Law Research call for a realignment in how we think about and approach the housing crisis — and eviction in particular — in America.